Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2023;13(3): 512-520. doi: 10.34172/apb.2023.062
PMID: 37646057        PMCID: PMC10460802

Mini Review

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors

Soheil Mehrdadi 1 * ORCID

Cited by CrossRef: 9

1- Mesut B, Al-Mohaya M, Gholap A, Yeşilkaya E, Das U, Akhtar M, Sah R, Khan S, Moin A, Faiyazuddin M. Demystifying the potential of lipid-based nanocarriers in targeting brain malignancies. Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397(12):9243 [Crossref]
2- Grzegorzewski J, Michalak M, Wołoszczuk M, Bulicz M, Majchrzak-Celińska A. Nanotherapy of Glioblastoma—Where Hope Grows. IJMS. 2025;26(5):1814 [Crossref]
3- Arafat M, Sakkal M, Beiram R, AbuRuz S. Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment—A Recent Review. Pharmaceuticals. 2024;17(3):315 [Crossref]
4- Abu-Hdaib B, Nsairat H, El-Tanani M, Al-Deeb I, Hasasna N. In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system . Nanomedicine. 2024;19(12):1087 [Crossref]
5- Mahendran G, Shangaradas A, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S, Silva G. Unlocking the epigenetic code: new insights into triple-negative breast cancer. Front Oncol. 2024;14 [Crossref]
6- Gao X, Ciura K, Ma Y, Mikolajczyk A, Jagiello K, Wan Y, Gao Y, Zheng J, Zhong S, Puzyn T, Gao X. Toward the Integration of Machine Learning and Molecular Modeling for Designing Drug Delivery Nanocarriers. Advanced Materials. 2024;36(45) [Crossref]
7- Zheng Y, Cui L, Lu H, Liu Z, Zhai Z, Wang H, Shao L, Lu Z, Song X, Zhang Y. Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers. IJN. 2024;Volume 19:12343 [Crossref]
8- Jawad M, Shafique U, Din F, Butt A, Khan S, Khan G, Alamri A, Lahiq A, Alsharif S, Almerai K. Nose to brain delivery of escitalopram-loaded nano-structured lipid carriers thermosensitive gel: Formulation, physiochemical, pharmacokinetic and pharmacodynamics evaluation. Journal of Drug Delivery Science and Technology. 2024;97:105800 [Crossref]
9- Peng X, Ma Y, Yan C, Wei X, Zhang L, Jiang H, Ma Y, Zhang S, Xing M, Gao Y. Mechanism, Formulation, and Efficacy Evaluation of Natural Products for Skin Pigmentation Treatment. Pharmaceutics. 2024;16(8):1022 [Crossref]
10- Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System. IJN. 2024;Volume 19:5581 [Crossref]
11- Kadhim S, Dehghan G, Mahdavi M. Ciprofloxacin-encapsulated solid lipid nanoparticles: a comprehensive biochemical analysis of cytotoxic effects, proliferation inhibition, and apoptotic induction in KG1-a leukemia cells. Med Oncol. 2025;42(3) [Crossref]
12- Li H, Guan M, Zhang N, Wang Y, Liang T, Wu H, Wang C, Sun T, Liu S. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities. Biomedicine & Pharmacotherapy. 2024;177:117011 [Crossref]